JBM (Healthcare) Limited (2161.HK)
2161.HK Stock Price Chart
Explore JBM (Healthcare) Limited interactive price chart. Choose custom timeframes to analyze 2161.HK price movements and trends.
2161.HK Company Profile
Discover essential business fundamentals and corporate details for JBM (Healthcare) Limited (2161.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
5 Feb 2021
Employees
279.00
Website
https://www.jbmhealthcare.com.hkCEO
Yat Wai Wong
Description
JBM (Healthcare) Limited, an investment holding company, develops, manufactures, markets, distributes, and sells healthcare and wellness products in Asia. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices; and pharmaceutical products. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.
2161.HK Financial Timeline
Browse a chronological timeline of JBM (Healthcare) Limited corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 11 Aug 2025
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 28 Aug 2025.
Earnings released on 12 Jun 2025
EPS came in at $0.12 , while revenue for the quarter reached $383.34M .
Dividend declared on 17 Dec 2024
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 15 Jan 2025.
Earnings released on 30 Sept 2024
EPS came in at $0.12 , while revenue for the quarter reached $398.95M .
Dividend declared on 15 Aug 2024
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 17 Sept 2024.
Earnings released on 30 Mar 2024
EPS came in at $0.08 , while revenue for the quarter reached $321.59M .
Dividend declared on 7 Dec 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 28 Dec 2023.
Earnings released on 30 Sept 2023
EPS came in at $0.07 , while revenue for the quarter reached $326.83M .
Dividend declared on 15 Aug 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 1 Sept 2023.
Earnings released on 31 Mar 2023
EPS came in at $0.04 , while revenue for the quarter reached $283.48M .
Dividend declared on 8 Dec 2022
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 29 Dec 2022.
Earnings released on 30 Sept 2022
EPS came in at $0.02 , while revenue for the quarter reached $236.85M .
Earnings released on 31 Mar 2022
EPS came in at $0.02 , while revenue for the quarter reached $216.77M .
Earnings released on 30 Sept 2021
EPS came in at $0.01 , while revenue for the quarter reached $189.37M .
Earnings released on 31 Mar 2021
EPS came in at $0.00 , while revenue for the quarter reached $201.05M .
Earnings released on 30 Sept 2020
EPS came in at $0.02 , while revenue for the quarter reached $196.11M .
2161.HK Stock Performance
Access detailed 2161.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.